At Pharmatech AI, we are proud to announce our strategic partnership with QuantifAI, an institutional-grade quant-trading platform combining advanced AI with blockchain’s transparency. As experts in AI-powered drug discovery, focusing on nanomedicine, pain therapy, natural products, and cannabinoid research, we are committed to pushing the boundaries of pharmaceutical innovation. This collaboration with QuantifAI enhances our...

At Pharmatech AI, we are proud to announce our strategic partnership with Wag3s, a leading Web3 platform for AI-driven accounting, crypto tax, and HR management. As experts in AI-powered drug discovery, focusing on nanomedicine, pain therapy, natural products, and cannabinoid research, we are committed to pushing the boundaries of pharmaceutical innovation. This collaboration with Wag3s...

At Pharmatech AI, we are excited to announce our strategic partnership with Router Protocol, a cutting-edge Layer-1 blockchain enabling chain abstraction and seamless ecosystem connectivity. As leaders in AI-driven drug discovery, specializing in nanomedicine, pain therapy, natural products, and cannabinoid research, we are dedicated to advancing innovative therapies through state-of-the-art technology. This collaboration with Router...

At Pharmatech AI, we are excited to announce our strategic partnership with Tenzor Assets, a leader in leveraging AI and mathematical models to evaluate intangible assets and manage financial risks across industries. As pioneers in AI-driven drug discovery, focusing on nanomedicine, pain therapy, natural products, and cannabinoid research, we are dedicated to accelerating innovative therapies....

At Pharmatech AI, we are thrilled to announce our strategic partnership with the International Intelligent Innovation Computing Center (IIICC). As a leading company in AI-driven drug discovery, specializing in nanomedicine, pain therapy, natural products, and cannabinoid research, we are committed to leveraging cutting-edge technologies to develop innovative therapies. This collaboration with IIICC, a pioneer in...

Germany, July 15, 2025 – Pharmatech AI has entered into a strategic collaboration with Deutsche Anbaugesellschaft DAG GmbH, marking a significant advancement in cannabinoid-based therapy development through artificial intelligence. This partnership combines Pharmatech AI’s cutting-edge AI technologies with DAG’s extensive expertise in cannabis cultivation and processing to create a powerful synergy in pharmaceutical research. Through...